Table 1 Basic characteristics of normal controls, essential hypertension patients with diabetes and without diabetes

Demographics

 Age, years

52.7±13.1

56.4±14.22

57.69±12.46

 Female, n (%)

26 (50.0%)

37 (48.7%)

24 (50%)

 BMI (kg/m²)

22.6±2.9

24.9±2.9*

24.2±2.6*

 BSA (m²)

1.65±0.18

1.7±0.16

1.68±0.13

Hemodynamic variables

 Systolic blood pressure (mm Hg)

114.8±10.1

143.2±20.7*

140.9±18.3*

 Diastolic blood pressure (mm Hg)

73.2±8.6

85.3±16.5*

81.6±10.2*

Laboratory data

 Fasting bloodglucose (mmol/L)

5.21±1.66

5.15±0.7

8.04±3.24*,#

 HbA1c, (%)

5.27±0.36

5.58±0.25

6.86±0.97*,#

 Plasma triglycerides (mmol/L)

1.35±0.51

1.49±1.08

1.32±0.55

 Total cholesterol (mmol/L)

4.71±0.96

4.44±0.89

4.01±1.87

 HDL (mmol/L)

1.34±0.33

1.32±0.48

1.34±1.37

 LDL (mmol/L)

2.55±0.76

2.53±0.72

2.38±1.11

 eGFR (mL/min/1.73 m2)

101.29±16.8

96.86±20.04

90.66±29.39

HTN treatment

 HTN duration (years)

–

6.8±7.9

5.7±5.6

 ACEI/ARB, n (%)

–

28 (40)

15 (35)

 Beta-blocker, n (%)

–

28 (40)

16 (40)

 Calcium channel blocker, n (%)

–

40 (55.7)

20 (47.5)

 Diuretics, n (%)

–

11 (15)

6 (15)

Diabetes treatment

 Diabetes duration (years)

–

–

8.22±4.07

 Oral, n (%)

–

–

40 (80.2)

 Insulin, n (%)

–

–

7 (15.6)